Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Biguanides, and Others), Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), End User (Male, Female), and Region 2025-2033

Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Biguanides, and Others), Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), End User (Male, Female), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5239

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Infertility Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Gonadotropin
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Aromatase Inhibitors
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Selective Estrogen Receptor Modulators (SERMs)
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Biguanides
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intravenous
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Subcutaneous
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Intramuscular
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by End User
    9.1    Male
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Female
        9.2.1 Market Trends
        9.2.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
        15.3.2    Bayer AG
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Ferring Pharmaceuticals
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Livzon Pharmaceutical Group Inc. 
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Mankind Pharma
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Merck & Co. Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Merck KGaA
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Novartis AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
        15.3.10    Sanofi S.A.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Theramex
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2024
Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2024
Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2024
Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: North America: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: United States: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: China: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: India: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: France: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2024
Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Infertility Drugs Market: Competitive Structure
Table 8: Global: Infertility Drugs Market: Key Players

Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Biguanides, and Others), Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), End User (Male, Female), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials